SomaLogic Issues Statement Correcting Madryn Asset Management's Misleading Disclosure

/PRNewswire/ -- SomaLogic, Inc. (Nasdaq: SLGC), a leader in proteomics technology, today issued the following statement in response to a press release issued...

Related Keywords

New York ,United States ,Jason Ryan ,Adam Taich ,Troy Cox ,Garheng Kong ,Tom Carey ,Marissa Bych ,Joele Frank ,Avinash Amin ,Ruben Gutierrez ,Adam Schecter ,Wilkinson Brimmer Katcher ,Adam Schechter ,Lyle Weston Carly King ,Linkedin ,Institutional Shareholder Services ,Exchange Commission ,Nasdaq ,Gilmartin Group ,Morrow Sodali ,Standard Biotool Investor Relations Department ,Somalogic Inc ,Somalogic Publishes Key Correspondence ,Undermine Confidence ,Thorough Strategic ,Value Maximizing Transaction ,Standard Biotools ,Best Interests ,All Stockholders ,Madryn Asset Management ,Christmas Eve ,Managing Director ,Lead Independent Director ,Madryn Capital Management ,Somalogic Board ,Tycho Peterson ,Ethan Skerry ,External Email ,Asset Management ,Special Meeting ,Standard Biotool ,Standard Biotool Investor Relations ,Somalogic Investor Relations ,Current Reports ,Securities Act ,Private Securities Litigation Reform Act ,Wilkinson Brimmer ,